Rabies Immune Globulin (Human)
Passive antibody preparation from human plasma of vaccinated donors, used post-exposure prophylaxis for rabies. HTS 3002.12.0090 covers this as other antisera/blood fractions for prophylactic therapeutic use. Biotech processes ensure high potency against rabies virus.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If equine rabies immunoglobulin
Animal plasma-derived versions classify under animal blood antisera.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Rabies neutralizing antibody (RFFIT) test reports mandatory for import validation
• Prior FDA notification via Prior Notice system for biologics expedites entry
Related Products under HTS 3002.12.00.90
Human Immunoglobulin G (IgG) Concentrate
A purified fraction of human blood plasma containing high levels of Immunoglobulin G antibodies, used therapeutically to treat primary immunodeficiencies and autoimmune disorders. It falls under HTS 3002.12.0090 as an immunological product derived from blood fractions, prepared for therapeutic use via biotechnological purification processes. This excludes simple blood products without specific immunological modification.
Cytomegalovirus (CMV) Hyperimmune Globulin
Hyperimmune plasma fraction enriched with CMV-specific antibodies for preventing CMV infection in transplant patients. Falls under HTS 3002.12.0090 as an other blood fraction/antisera prepared for prophylactic use through plasma fractionation. It meets the definition of immunological products from human blood.
Botulinum Toxin Type A Immune Globulin
Antitoxin derived from human plasma fractions containing antibodies against botulinum toxin, used to treat infant botulism. Classified in HTS 3002.12.0090 as an immunological blood fraction for therapeutic neutralization of toxins. It involves biotech purification of specific antisera.
Tetanus Immune Globulin (TIG)
Human blood fraction providing passive immunity against tetanus toxin for wound management. Under HTS 3002.12.0090 as other blood fraction antisera prepared for therapeutic use. Involves hyperimmunization and plasma fractionation.
Hepatitis B Immune Globulin (HBIG)
Plasma-derived antibodies specific to hepatitis B surface antigen for post-exposure prophylaxis in high-risk cases. Classifies in HTS 3002.12.0090 as an immunological blood fraction/antiserum. Biotechnological pooling and purification ensure specificity.
Varicella Zoster Immune Globulin (VZIG)
Human immune globulin enriched for varicella-zoster virus antibodies to prevent severe chickenpox in immunocompromised patients. HTS 3002.12.0090 for other specific antisera from blood fractions. Prepared via donor plasmapheresis and affinity purification.